NO20034679L - Process of purifying 6-methoxyomeprazole - Google Patents

Process of purifying 6-methoxyomeprazole

Info

Publication number
NO20034679L
NO20034679L NO20034679A NO20034679A NO20034679L NO 20034679 L NO20034679 L NO 20034679L NO 20034679 A NO20034679 A NO 20034679A NO 20034679 A NO20034679 A NO 20034679A NO 20034679 L NO20034679 L NO 20034679L
Authority
NO
Norway
Prior art keywords
methoxyomeprazole
purifying
Prior art date
Application number
NO20034679A
Other languages
Norwegian (no)
Other versions
NO20034679D0 (en
Inventor
Linda Whittal
Grayson Walker Stowell
Robert R Whittle
Original Assignee
Aai Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/839,449 external-priority patent/US6608091B2/en
Priority claimed from US09/839,395 external-priority patent/US6673936B2/en
Application filed by Aai Pharma Inc filed Critical Aai Pharma Inc
Publication of NO20034679L publication Critical patent/NO20034679L/en
Publication of NO20034679D0 publication Critical patent/NO20034679D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20034679A 2001-04-20 2003-10-20 Process of purifying 6-methoxyomeprazole NO20034679D0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/839,449 US6608091B2 (en) 2001-04-20 2001-04-20 Process for purifying 6-methoxy omeprazole
US09/839,395 US6673936B2 (en) 2001-04-20 2001-04-20 Process for purifying 6-methoxy omeprazole
PCT/US2002/015254 WO2002085312A2 (en) 2001-04-20 2002-04-17 Process for purifying 6-methoxy omeprazole

Publications (2)

Publication Number Publication Date
NO20034679L true NO20034679L (en) 2003-10-20
NO20034679D0 NO20034679D0 (en) 2003-10-20

Family

ID=27126104

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034679A NO20034679D0 (en) 2001-04-20 2003-10-20 Process of purifying 6-methoxyomeprazole

Country Status (8)

Country Link
EP (1) EP1379518A2 (en)
JP (1) JP2004528331A (en)
KR (1) KR20030088506A (en)
CN (1) CN100503596C (en)
CA (1) CA2443605A1 (en)
HU (1) HUP0304004A2 (en)
NO (1) NO20034679D0 (en)
WO (1) WO2002085312A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0204215B1 (en) * 1985-05-24 1993-08-11 G.D. Searle & Co. 2-[(1H-benzimidazol-2-ylsulfinyl)methyl]-benzenamines
AU6937700A (en) * 1999-08-26 2001-03-19 Applied Analytical Industries, Inc. Ft-raman spectroscopic measurement of omeprazole isomer ratio in a composition

Also Published As

Publication number Publication date
EP1379518A2 (en) 2004-01-14
WO2002085312A2 (en) 2002-10-31
KR20030088506A (en) 2003-11-19
CA2443605A1 (en) 2002-10-31
HUP0304004A2 (en) 2004-04-28
NO20034679D0 (en) 2003-10-20
JP2004528331A (en) 2004-09-16
WO2002085312A3 (en) 2003-04-03
CN100503596C (en) 2009-06-24
CN1503791A (en) 2004-06-09

Similar Documents

Publication Publication Date Title
NO20025814L (en) Method of well completion
NO20035426L (en) Method of administering anti-TNF-D antibody
NO20042680L (en) Processes for the preparation of O-demethylvenflaxine
DE60221619D1 (en) Process for the purification of synthesis gas
NO20023928D0 (en) Process for the preparation of citalopram
NO20024007L (en) Process for the preparation of citalopram
NO20040027L (en) Process for the preparation of escitalopram
DE60218451D1 (en) 15-KETO-PROSTAGLANDINE FOR THE TREATMENT OF DRUG-INDUCED OBSTIPATION
NO20040292L (en) Process for Preparation of 4-Aminodiphenylamine
HUP0302530A3 (en) Process for the purification of 2-nitro-4-methylsulphonylbenzoic acid
NO20024180D0 (en) Process for the preparation of citalopram
NO20035538D0 (en) Process for the preparation of zaleplon
NO20024213D0 (en) Process for the preparation of citalopram
NO20015766L (en) Process of oil production
NO20035136D0 (en) Process for the preparation of imipenem
NO20024214D0 (en) Process for the preparation of citalopram
FI20010472A0 (en) Process of hydration of the alphapine
NO20034679L (en) Process of purifying 6-methoxyomeprazole
NO20043935L (en) Process for the preparation of interferon
NO20024678L (en) Process of selective N-formylation of N-hydroxylamines
NO20011136L (en) Process of construction treatment
NO20034972L (en) Treatment of ADHD
NO20041193L (en) Process for the preparation of beta-ionylidene acetaldehyde
NO20022643D0 (en) reduction Process
FI20011469A (en) Process for the purification of flue gases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application